Marple Bradley F, Fornadley John A, Patel Alpen A, Fineman Stanley M, Fromer Leonard, Krouse John H, Lanier Bobby Q, Penna Peter
University of Texas Southwestern Medical School, Dallas, TX 75390-7208, USA.
Otolaryngol Head Neck Surg. 2007 Jun;136(6 Suppl):S107-24. doi: 10.1016/j.otohns.2007.02.031.
The American Academy of Otolaryngic Allergy (AAOA) convened an expert, multidisciplinary Working Group on Allergic Rhinitis to discuss patients' self-treatment behaviors and how health care providers approach and treat the condition. PROCEDURES AND DATA SOURCES: Co-moderators, who were chosen by the AAOA Board of Directors, were responsible for initial agenda development and selection of presenters and participants, based on their expertise in diagnosis and treatment of allergic rhinitis. Each presenter performed a literature search from which a presentation was developed, portions of which were utilized in developing this review article.
Allergic rhinitis is a common chronic condition that has a significant negative impact on general health, co-morbid illnesses, productivity, and quality of life. Treatment of allergic rhinitis includes avoidance of allergens, immunotherapy, and/or pharmacotherapy (ie, antihistamines, decongestants, corticosteroids, mast cell stabilizers, anti-leukotriene agents, anticholinergics). Despite abundant treatment options, 60% of all allergic rhinitis patients in an Asthma and Allergy Foundation of America survey responded that they are "very interested" in finding a new medication and 25% are "constantly" trying different medications to find one that "works." Those who were dissatisfied also said their health care provider does not understand their allergy treatment needs and does not take their allergy symptoms seriously. Dissatisfaction leads to decreased compliance and an increased reliance on multiple agents and over-the-counter products. Furthermore, a lack of effective communication between health care provider and patient leads to poor disease control, noncompliance, and unhappiness in a significant portion of patients.
Health care providers must gain a greater understanding of patient expectations to increase medication compliance and patient satisfaction and confidence.
美国耳鼻咽喉过敏学会(AAOA)召集了一个关于变应性鼻炎的多学科专家工作组,以讨论患者的自我治疗行为,以及医疗服务提供者如何处理和治疗该疾病。
由AAOA董事会选出的共同主持人负责初步议程的制定以及演讲者和参与者的挑选,这是基于他们在变应性鼻炎诊断和治疗方面的专业知识。每位演讲者进行了文献检索,并据此制作了一份报告,本综述文章的部分内容即来源于此。
变应性鼻炎是一种常见的慢性疾病,对总体健康、共病、生产力和生活质量有重大负面影响。变应性鼻炎的治疗包括避免接触过敏原、免疫疗法和/或药物治疗(即抗组胺药、减充血剂、皮质类固醇、肥大细胞稳定剂、抗白三烯药物、抗胆碱能药物)。尽管有丰富的治疗选择,但在美国哮喘和过敏基金会的一项调查中,60%的变应性鼻炎患者表示他们“非常有兴趣”寻找一种新药物,25%的患者“一直在”尝试不同的药物以找到一种“有效的”药物。那些不满意的患者还表示,他们的医疗服务提供者不了解他们的过敏治疗需求,也不重视他们的过敏症状。不满意会导致依从性下降,对多种药物和非处方产品的依赖增加。此外,医疗服务提供者与患者之间缺乏有效的沟通会导致很大一部分患者疾病控制不佳、不依从和不满意。
医疗服务提供者必须更好地了解患者的期望,以提高药物依从性以及患者的满意度和信心。